The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor curative effect of radioiodine therapy in papillary thyroid cancer

被引：0
|
作者：
Jingjia Cao
Xiaolu Zhu
Yaru Sun
Xiao Li
Canhua Yun
Wei Zhang
机构：
[1] the Second Hospital,Department of Nuclear Medicine
[2] Cheeloo College of Medicine,undefined
[3] Shandong University,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2022年 / 49卷
关键词：
BRAF V600E; TERT promoter mutation; Radioiodine therapy; Papillary thyroid carcinoma; Therapy response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3470 / 3481
页数：11
相关论文
共 50 条
  • [21] TERT and BRAF V600E mutations in thyroid cancer of World Trade Center Responders
    van Gerwen, Maaike
    Cerutti, Janete Maria
    Mendes, Thais Biude
    Brody, Rachel
    Genden, Eric
    Riggins, Gregory J.
    Taioli, Emanuela
    CARCINOGENESIS, 2023, 44 (04) : 350 - 355
  • [22] Papillary thyroid carcinomas with and without BRAF? V600E mutations are morphologically distinct
    Finkelstein, Alexander
    Levy, Gillian H.
    Hui, Pei
    Prasad, Avinash
    Virk, Renu
    Chhieng, David C.
    Carling, Tobias
    Roman, Sanziana A.
    Sosa, Julie A.
    Udelsman, Robert
    Theoharis, Constantine G.
    Prasad, Manju L.
    HISTOPATHOLOGY, 2012, 60 (07) : 1052 - 1059
  • [23] BRAF V600E in Pediatric Papillary Thyroid Carcinomas
    Paulson, V. A.
    Hollowell, M. L.
    Huang, S. A.
    Barletta, J. A.
    LABORATORY INVESTIGATION, 2014, 94 : 157A - 157A
  • [24] BRAF V600E and lymph node metastases in papillary thyroid cancer
    Chen, Pan
    Pan, Liqin
    Huang, Wensi
    Feng, Huijuan
    Ouyang, Wei
    Wu, Juqing
    Wang, Jing
    Deng, Yuying
    Luo, Jiaxin
    Chen, Yanying
    ENDOCRINE CONNECTIONS, 2020, 9 (10) : 999 - 1008
  • [25] BRAF V600E in Pediatric Papillary Thyroid Carcinomas
    Paulson, V. A.
    Hollowell, M. L.
    Huang, S. A.
    Barletta, J. A.
    MODERN PATHOLOGY, 2014, 27 : 157A - 157A
  • [26] The BRAF V600E mutation predicts poor survival outcome in patients with papillary thyroid carcinoma: a meta analysis
    Li, Jianhua
    Zhang, Shuijun
    Zheng, Shouhua
    Zhang, Danhua
    Qiu, Xinguang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (12): : 22246 - U565
  • [27] BRAF V600E/TERT promoter mutations and NIS/TSHR expression in differentiated thyroid carcinoma and their clinical significance
    Xiaoting Ru
    Qinjiang Liu
    Haihong Zhou
    Rong Yang
    Lie Bao
    Oncology and Translational Medicine, 2017, 3 (02) : 71 - 76
  • [28] Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation
    Ja Seong Bae
    Yourha Kim
    Sora Jeon
    Se Hee Kim
    Tae Jung Kim
    Sohee Lee
    Min-Hee Kim
    Dong Jun Lim
    Youn Soo Lee
    Chan Kwon Jung
    Diagnostic Pathology, 11
  • [29] Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation
    Bae, Ja Seong
    Kim, Yourha
    Jeon, Sora
    Kim, Se Hee
    Kim, Tae Jung
    Lee, Sohee
    Kim, Min-Hee
    Lim, Dong Jun
    Lee, Youn Soo
    Jung, Chan Kwon
    DIAGNOSTIC PATHOLOGY, 2016, 11
  • [30] BRAF V600E Mutations in Infarcted Thyroid Carcinoma
    Kouba, Erik
    Ford, Andrew
    Brown, Charmaine G.
    Yeh, Chen
    Kim, Hyung-Gyoon
    Siegal, Gene P.
    Manne, Upender
    Eltoum, Isam-Eldin
    LABORATORY INVESTIGATION, 2017, 97 : 327A - 327A
12345